Holen Sie sich die Stockscreener-App
0.00
100.00%
-11.00
Handel nachbörslich:
11.00
11.00
+
Schlusskurs vom Vortag:
$11.00
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$18.95M
Einnahmen:
$14.42M
Nettoeinkommen (Verlust:
$-5.23M
KGV:
0.00
EPS:
-2.3826
Netto-Cashflow:
$-3.32M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$11.00
Evoke Pharma Inc Stock (EVOK) Company Profile
Firmenname
Evoke Pharma Inc
Sektor
Telefon
858-345-1494
Adresse
420 STEVENS AVENUE, SOLANA BEACH, CA
Compare EVOK vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
0.00 | 18.95M | 14.42M | -5.23M | -3.32M | -2.3826 |
TAK
Takeda Pharmaceutical Co Adr
|
17.83 | 56.33B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.67 | 48.83B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
10.07 | 44.83B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.73 | 33.46B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
524.28 | 22.98B | 3.18B | 1.33B | 1.04B | 27.90 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Fortgesetzt | FBR & Co. | Buy |
| 2017-03-16 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-01-30 | Hochstufung | Laidlaw | Neutral → Buy |
| 2017-01-05 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Bestätigt | Rodman & Renshaw | Neutral |
| 2016-07-19 | Bestätigt | FBR Capital | Outperform |
| 2016-07-19 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-07-18 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Eingeleitet | Northland Capital | Outperform |
| 2016-03-14 | Bestätigt | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Fortgesetzt | FBR Capital | Outperform |
| 2014-12-03 | Bestätigt | MLV & Co | Buy |
| 2014-11-07 | Eingeleitet | MLV & Co | Buy |
| 2014-04-22 | Eingeleitet | Laidlaw | Buy |
| 2013-11-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
If You Invested $1,000 in Biofrontera Inc (BFRI) - Stock Titan
If You Invested $1,000 in Cbdmd Inc (YCBD) - Stock Titan
If You Invested $1,000 in Therapeuticsmd Inc (TXMD) - Stock Titan
If You Invested $1,000 in Evoke Pharma Inc (EVOK) - Stock Titan
Earnings Report: Is Evoke Pharma Inc stock a hidden gemWeekly Trade Analysis & Technical Confirmation Trade Alerts - baoquankhu1.vn
Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In - MSN
Movement Recap: How does Evoke Pharma Inc compare to its peersMarket Volume Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Winners Losers: What technical signals suggest for AAM.U stock2025 Risk Factors & Verified Momentum Stock Alerts - Naître et grandir
Momentum Shift: Will Evoke Pharma Inc benefit from geopolitical trendsEarnings Trend Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Gastroparesis Market: Rapid Increment Driven by Innovation by 2034DelveInsight - openPR.com
EVOK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evoke Pharma Inc. a strong growth stock2025 Trading Recap & AI Forecasted Entry and Exit Points - mfd.ru
Can Evoke Pharma Inc. stock rebound after recent weaknessPortfolio Return Summary & Advanced Technical Analysis Signals - mfd.ru
Why Evoke Pharma Inc. stock could rally in 20252025 Price Action Summary & Daily Stock Trend Watchlist - mfd.ru
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations for Kenvue Inc. (NYSEKVUE), Sonida Senior Living, Inc. (NYSESNDA), Evoke Pharma Inc. (NasdaqEVOK), and SM Energy Company (NYSESM) - Intellectia AI
Does ProShares Trust ProShares Short 7 10 Year Treasury have declining or rising EPSJuly 2025 Update & Weekly High Momentum Picks - mfd.ru
Is IMOS still a buy after recent gainsPortfolio Gains Report & Weekly Hot Stock Watchlists - mfd.ru
EVOK Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Evoke Pharma’s Volatile Micro?Cap Ride: Can EVOK Break Out Of Its Downtrend? - AD HOC NEWS
Why analysts upgrade Evoke Pharma Inc. stockJuly 2025 PostEarnings & Safe Capital Growth Tips - mfd.ru
How Evoke Pharma Inc. stock performs in interest rate cyclesJuly 2025 Rallies & Verified Entry Point Signals - mfd.ru
Big Money Moves: What is Evoke Pharma Incs 5 year growth outlookJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Can enGene Holdings Inc. Equity Warrant grow without external fundingJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - mfd.ru
Market Recap: Is Artivion Inc stock undervalued right now2025 Technical Patterns & Technical Pattern Alert System - baoquankhu1.vn
Gastroparesis Treatment Market 2026-2033: Growth Overview, - openPR.com
Will Evoke Pharma Inc. stock attract more institutional investors - mfd.ru
Income Plays: What is Evoke Pharma Incs 5 year growth outlook2025 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn
Can Evoke Pharma Inc. continue delivering strong returnsCPI Data & High Conviction Investment Ideas - mfd.ru
How cyclical is Evoke Pharma Inc.’s revenue streamQuarterly Performance Summary & Consistent Return Strategy Ideas - mfd.ru
Institution Moves: Can Evoke Pharma Inc grow without dilutionWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Moving Averages: Is Evoke Pharma Inc a speculative investment2025 Valuation Update & Consistent Growth Stock Picks - baoquankhu1.vn
Is Evoke Pharma Inc.’s ROE strong enoughWeekly Trade Summary & Weekly Chart Analysis and Guides - bollywoodhelpline.com
IPO Launch: Is Evoke Pharma Inc stock heavily shortedJuly 2025 Fed Impact & Low Risk Entry Point Guides - baoquankhu1.vn
Evoke Pharma Leads Stock Performance with 149.43% Return Over Past Year - Markets Mojo
Evoke Pharma Achieves 313.53% Return, Leading Recent Stock Performers - Markets Mojo
Is Evoke Pharma Inc. a speculative investmentEarnings Risk Report & Fast Gaining Stock Strategy Reports - bollywoodhelpline.com
Evoke Pharma (NASDAQ:EVOK) Stock Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
US Market Wrap: What are analysts price targets for Evoke Pharma Inc2025 Fundamental Recap & Low Risk Entry Point Guides - baoquankhu1.vn
AI Stocks: Is Evoke Pharma Inc a speculative investmentJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Wall Street Recap: Will Evoke Pharma Inc benefit from seasonalityJuly 2025 PostEarnings & Low Risk Entry Point Guides - baoquankhu1.vn
Evoke Pharma Leads Micro-Cap Stocks with 137.07% Return Over Past Year - Markets Mojo
Evoke Pharma Leads Micro-Cap Stocks with 149.43% Return Over Past Year - MarketsMojo
Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance - MarketsMojo
Will Evoke Pharma Inc. stock benefit from commodity prices2025 AllTime Highs & Low Risk High Win Rate Picks - Улправда
How The Story Behind Evoke (LSE:EVOK) Is Changing With Takeover Terms And UK Gaming Tax - Yahoo Finance
Evoke Pharma Achieves 313.53% Return Amid Mixed Micro-Cap Performance - Markets Mojo
What technical charts say about Evoke Pharma Inc. stock - ulpravda.ru
Will Evoke Pharma Inc. stock keep outperforming rivalsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - Улправда
Will Evoke Pharma Inc. stock gain from strong economyWeekly Profit Analysis & High Accuracy Trade Alerts - ulpravda.ru
Why Evoke Pharma Inc. stock is considered a top pickEarnings Trend Report & Fast Entry High Yield Stock Tips - Улправда
How Evoke Pharma Inc. stock performs in rate cut cyclesWeekly Trade Summary & Capital Efficiency Focused Strategies - Улправда
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):